Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The identification of CD36+ CAFs as a key driver of immunosuppression in osteosarcoma has opened new avenues for targeted intervention (35)
Reported or proposed issue Long-term or repeated-cycle effects Evidence source No long-term human trial Known or theoretical
Food Chem
The enhanced cellular uptake supports comprehensive antioxidant network function while providing superior individual performance
US$ 26.80
US$ 20.27
US$ 26.04
US$ 28.43
US$ 23.14
US$ 23.68
US$ 21.30
US$ 21.90
